In the BioHarmony Drug Report Database

"Preview" Icon

Fenoldopam

Corlopam (fenoldopam) is a small molecule pharmaceutical. Fenoldopam was first approved as Corlopam on 1997-09-23. It is used to treat heart failure, malignant hypertension, and renovascular hypertension in the USA. The pharmaceutical is active against D(1A) dopamine receptor. In addition, it is known to target D(4) dopamine receptor and D(1B) dopamine receptor.

 

Trade Name

 

Corlopam
 

Common Name

 

fenoldopam
 

ChEMBL ID

 

CHEMBL588
 

Indication

 

heart failure, malignant hypertension, renovascular hypertension
 

Drug Class

 

Image (chem structure or protein)

Fenoldopam structure rendering